N-(1H-benzimidazol-2-yl)isobutyramide | 17228-23-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: N-(1H-benzimidazol-2-yl)isobutyramide
• 英文别名: Propionamide, N-(benzimidazol-2-yl)-2-methyl-；N-(1H-benzimidazol-2-yl)-2-methylpropanamide
• CAS: 17228-23-8
• 化学式: C₁₁H₁₃N₃O
• mdl: MFCD03235484
• 分子量: 203.244
• InChiKey: JVFBVPWDPRTTLQ-UHFFFAOYSA-N

物化性质

• 密度：
  1.257±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.272
• 拓扑面积：
  57.8
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  N-(bis-methylsulfanyl-methylene)-isobutylamide 、 邻苯二胺 以 N,N-二甲基甲酰胺 为溶剂， 反应 9.0h， 以40%的产率得到N-(1H-benzimidazol-2-yl)isobutyramide
  参考文献：
  名称：

  Lee, An Ha; An, Mi Hyun; Choi, Eun Hyun, Heterocycles, 2006, vol. 70, p. 571 - 580

  摘要：

  DOI：

文献信息

• Graubaum, Heinz; Martin, Dieter; Csunderlik, Carol, Zeitschrift fur Chemie, 1984, vol. 24, # 2, p. 57 - 58
  作者：Graubaum, Heinz、Martin, Dieter、Csunderlik, Carol、Glatt, Hans-Horst、Bacaloglu, Radu、Malurea-Munteanu, Mirela

  DOI：——

  日期：——
• PTSA catalyzed straightforward protocol for the synthesis of 2-(N-acyl)aminobenzimidazoles and 2-(N-acyl)aminobenzothiazoles in PEG
  作者：Siddaiah Vidavalur、Mahaboob Basha Gajula、Ramu Tadikonda、Mangarao Nakka、Sudhakar Dega、Santosh Kumar Yadav、Christopher Voosala

  DOI：10.1016/j.tetlet.2014.03.040

  日期：2014.4

  An efficient PTSA catalyzed synthesis of 2-(N-acyl)aminobenzimidazoles and 2-(N-acyl)aminobenzothiazoles has been described using S-ethylated-N-acylthioureas as substrates and polyethylene glycol as solvent. (C) 2014 Elsevier Ltd. All rights reserved.
• Alternative and efficient method for the preparation of 2-acetamidobenzimidazoles
  作者：Burkhon Elmuradov、Asqar Abdurazakov、Rasul Okmanov、Sarvar Saidov、Shoxrux Kubayev

  DOI：10.21608/ejchem.2021.53188.3102

  日期：2021.2.13
• GRAUBAUM, H.;MARTIN, D.;CSUNDERLIK, C.;GLATT, H. -H.;BACALOGEU, R.;MUNTEA+, Z. CHEM., 1984, 24, N 2, 57-58
  作者：GRAUBAUM, H.、MARTIN, D.、CSUNDERLIK, C.、GLATT, H. -H.、BACALOGEU, R.、MUNTEA+

  DOI：——

  日期：——
• SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
  申请人：GlaxoSmithKline Intellectual Property (No.2) Limited

  公开号：US20170355705A1

  公开（公告）日：2017-12-14

  The present invention relates to novel substituted bridged urea analog compounds of Formula (I) or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds, alone or in combination with other therapeutic agents, as Sirtuin Modulators useful for increasing lifespan of a cell, and for use in treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.

表征谱图